Growth equity fund research profile
Epiq Capital II is a concentrated India growth-equity fund backing late-stage technology and consumer businesses. Public manager and fund records identify Lenskart, Zepto, Giva, Bhanzu, Cure.fit, Pristyn Care, Dailyhunt and Park+ as attributable companies across the Epiq platform and current Fund II-era disclosures.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Epiq Capital II uses a growth equity; late-stage technology and consumer platforms approach across Consumer technology, SaaS, fintech, healthcare technology.
Current evidence
Epiq’s current 2026 website continues to identify its growth and late-stage mandate and portfolio founders, while 2025 prospectus records and the manager’s FY25 update identify ongoing Fund II-era holdings and activity.
Strategy
Growth equity; late-stage technology and consumer platforms
Sector focus
Consumer technology, SaaS, fintech, healthcare technology
AIF structure context
Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.
Current signal
Epiq’s current 2026 website continues to identify its growth and late-stage mandate and portfolio founders, while 2025 prospectus records and the manager’s FY25 update identify ongoing Fund II-era holdings and activity.
Investor questions
Epiq Capital II is covered in Rupeia's private equity research universe. The current public record describes the strategy as Growth equity; late-stage technology and consumer platforms, with a sector focus of Consumer technology, SaaS, fintech, healthcare technology. The profile should be read with the linked source trail and Typical route: Category II AIF context.
The profile displays only company or asset names attributable to Epiq Capital II in the reviewed public sources: Lenskart; Zepto; Giva; Bhanzu; Cure.fit; Pristyn Care; Dailyhunt; Park+. It does not represent a complete current portfolio unless the manager has published one.
Epiq closed Fund II at $225 million in 2023. 2025 public records document Epiq’s continuing position in Lenskart and the manager’s FY25 portfolio activity includes Zepto, Giva and Bhanzu; vehicle-level realised-return metrics are not publicly disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: Fund II final close: $225 million in June 2023; initial target was $150 million. These are vehicle-specific figures.. Public terms or access information: Growth and late-stage technology investing in approximately 8–12 companies with public reporting of roughly $20–25 million average cheques. Complete fees, carry, hurdle, tenor and reserve terms are not disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Rishi Navani (Founder & Managing Partner); Dheeraj Aggarwal (Partner); Aditya Pokharna (CFO and Head of Fund Operations); Navjot Kaur (Director, Fundraising and Investor Relations). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: The fund does not publish audited vehicle-level net returns, fees, carry, reserve policy or a complete current allocation schedule. The named companies are supported by manager portfolio pages, fund reporting and issuer or public transaction records; the record does not infer ownership or current status beyond those sources..
2025-07-04: Epiq’s current 2026 website continues to identify its growth and late-stage mandate and portfolio founders, while 2025 prospectus records and the manager’s FY25 update identify ongoing Fund II-era holdings and activity.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.